Detailed Information on Publication Record
2019
ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer
ESTEBAN-GIL, Angel, Fernando PEREZ-SANZ, Jose GARCIA-SOLANO, Begona ALBURQUERQUE-GONZALEZ, Maria PARRENO-GONZALEZ et. al.Basic information
Original name
ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer
Authors
ESTEBAN-GIL, Angel (724 Spain, guarantor), Fernando PEREZ-SANZ (724 Spain), Jose GARCIA-SOLANO (724 Spain), Begona ALBURQUERQUE-GONZALEZ (724 Spain), Maria PARRENO-GONZALEZ (724 Spain), Maria del Carmen LEGAZ-GARCIA (724 Spain), Jesualdo Tomas FERNANDEZ-BREIS (724 Spain), Edith RODRIGUEZ-BRAUN (724 Spain), Paola PIMENTEL (724 Spain), Anne TUOMISTO (246 Finland), Markus MAKINEN (246 Finland), Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Pablo CONESA-ZAMORA (724 Spain)
Edition
SCIENTIFIC DATA, LONDON, NATURE PUBLISHING GROUP, 2019, 2052-4463
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.541
RIV identification code
RIV/00216224:14740/19:00112508
Organization unit
Central European Institute of Technology
UT WoS
000494480700001
Keywords in English
MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; SERRATED POLYPS; COLON-CANCER; PHENOTYPE; CARCINOGENESIS; ADENOCARCINOMA; BIOMARKERS; PATHWAYS; GENES
Tags
International impact, Reviewed
Změněno: 26/2/2020 12:38, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Colorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbiota and altered microRNA expression in CRC carcinogenesis, but their relationship with pathological drivers or molecular phenotypes is not clearly established. Joint analysis of clinical and omics data can help clarify such relations. We present ColPortal, a platform that integrates transcriptomic, microtranscriptomic, methylomic and microbiota data of patients with colorectal cancer. ColPortal also includes detailed information of histological features and digital histological slides from the study cases, since histology is a morphological manifestation of a complex molecular change. The current cohort consists of Caucasian patients from Europe. For each patient, demographic information, location, histology, tumor staging, tissue prognostic factors, molecular biomarker status and clinical outcomes are integrated with omics data. ColPortal allows one to perform multiomics analyses for groups of patients selected by their clinical data.